GTCR’s Sterigenics' $805 mln buy of Nordion to close this week
The final regulatory hurdle to the US$805 million acquisition of Nordion Inc (TSX:NDN) by Sterigenics International Inc has been cleared. As a result, the Ottawa-based medical isotope supplier said the proposed deal is expected to close on or about Aug. 6. Reuters previously reported that Sterigenics, a sterilization services provider owned by U.S. private equity firm GTCR LLC, has twice raised the buyout offer for Nordion from its US$727 million bid in reaction to an unnamed third party’s interest. The acquisition, which was approved by Nordion shareholders in June, followed a strategic review process launched by the company in January 2013.
5 August 2014•4 mins read
